Data / Form D filings / Better Therapeutics, Inc.
Better Therapeutics, Inc.: Form D filings
Better Therapeutics, Inc., a biotechnology company in San Francisco, CA, filed 3 Form D notices with the SEC between 2023 and 2024. The latest, on January 23, 2024, reports $250,000 sold of a $250,000 offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 548 MARKET ST. #49404, San Francisco, CA, 94101
- Phone
- (415) 887-2311
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1832415
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 23, 2024 | New notice | $250,000 | $250,000 | 1 | Jan 9, 2024 | sec.gov | |
| Aug 11, 2023 | New notice | $2,114,998 | $2,114,998 | 10 | Jul 27, 2023 | sec.gov | |
| Apr 21, 2023 | New notice | $6,500,001 | $6,500,001 | 9 | Apr 6, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Elder Granger | Director | |
| Richard Carmona | Director | |
| Risa Lavizzo-Mourey | Director | |
| David Perry | Executive Officer, Director | |
| Kristin Wynholds | Executive Officer | |
| Geoffrey Parker | Director | |
| Frank Karbe | Executive Officer, Director | |
| Andrew Armanino | Director | |
| Mark Berman | Executive Officer |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jan 22, 2024 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Better Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.